SMTL ID : 5is5.1

Discovery and Pharmacological Characterization of Novel Quinazoline-based PI3K delta-selective Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.85 Å

Oligo State

monomer

Ligands

1 x 6CY: 5-{4-[3-(4-acetylpiperazine-1-carbonyl)phenyl]quinazolin-6-yl}-2-methoxypyridine-3-carbonitrile(Non-covalent)

6CY.1: 18 residues within 4Å: Chain A: T.750, M.752, P.758, W.760, I.777, K.779, L.784, D.787, Y.813, I.825, E.826, V.827, V.828, S.831, T.833, M.900, I.910, D.911 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:W.760, A:I.777, A:I.825, A:T.833, A:I.910 Hydrogen bonds: A:K.779, A:V.828, A:S.831, A:D.911 Water bridges: A:F.912 pi-Stacking: A:Y.813

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hoegenauer, K. et al., Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors. Acs Med.Chem.Lett. (2016)

Release Date

2016-08-10

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform